1. Home
  2. KIDS vs ZVRA Comparison

KIDS vs ZVRA Comparison

Compare KIDS & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OrthoPediatrics Corp.

KIDS

OrthoPediatrics Corp.

N/A

Current Price

$22.10

Market Cap

512.4M

Sector

Health Care

ML Signal

N/A

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$12.39

Market Cap

562.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KIDS
ZVRA
Founded
2007
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
512.4M
562.2M
IPO Year
2016
2015

Fundamental Metrics

Financial Performance
Metric
KIDS
ZVRA
Price
$22.10
$12.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$24.67
$23.00
AVG Volume (30 Days)
178.5K
791.8K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
159.21
EPS
N/A
0.74
Revenue
$98,049,000.00
$106,470,000.00
Revenue This Year
$14.07
$37.27
Revenue Next Year
$11.85
$53.42
P/E Ratio
N/A
$17.13
Revenue Growth
37.95
350.91
52 Week Low
$14.42
$7.16
52 Week High
$26.74
$15.04

Technical Indicators

Market Signals
Indicator
KIDS
ZVRA
Relative Strength Index (RSI) 40.85 62.06
Support Level $17.54 $12.18
Resistance Level $26.74 $14.27
Average True Range (ATR) 0.84 0.38
MACD -0.45 0.11
Stochastic Oscillator 7.14 83.05

Price Performance

Historical Comparison
KIDS
ZVRA

About KIDS OrthoPediatrics Corp.

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: